Agios Pharmaceuticals Inc (AGIO): Next-Year EPS Estimate 26.11%
As of 2026-07-17, Agios Pharmaceuticals Inc (AGIO) has a next-year EPS growth estimate of 26.11%.
Analyst estimates for AGIO have remained steady in the most recent observable window, with next-year EPS growth projected at 26.11%. Current-year growth stands at 12.67%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 26.11%
- EPS growth this year
- 12.67%
- EPS next quarter (est)
- -$1.66
- Last price
- $39.61
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-17 | 26.11% | 12.67% | -$1.66 | $39.61 |
| 2026-07-16 | 26.11% | 12.67% | -$1.66 | $38.72 |
| 2026-07-15 | 26.11% | 12.67% | -$1.66 | $39.87 |
| 2026-07-14 | 26.11% | 12.67% | -$1.66 | $39.92 |
| 2026-07-13 | 26.11% | 12.67% | -$1.66 | $40.55 |
| 2026-07-12 | 26.11% | 12.67% | -$1.66 | $41.23 |
| 2026-07-09 | 26.11% | 12.67% | -$1.66 | $42.79 |
| 2026-07-08 | 26.11% | 12.67% | -$1.66 | $42.76 |
| 2026-07-07 | 26.11% | 12.67% | -$1.66 | $44.01 |
Recent News
Screen Performance
Aggregate stats across all 1864 tickers our top-EPS-revision screen has flagged over the past 107 days.
- Median return since detection
- +2.5%
- % of tickers in the green
- 55%
- Median return on winners
- +20.8%
- Large revisions captured
- 1048
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Agios Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-07-17, Agios Pharmaceuticals Inc (AGIO) has a next-year EPS growth estimate of 26.11%, based on analyst consensus.
What sector and industry does Agios Pharmaceuticals Inc belong to?▾
Agios Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AGIO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Agios Pharmaceuticals Inc (AGIO) appears here because it was detected by our daily top-EPS-revision-performer screen.